Study results of novel drug-eluting technology highlight potential durability of TAR-200 in patient population with high unmet need CHICAGO, April 30, 2023 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first results from the open-label Phase…

BETHESDA, Maryland, 30 de abril de 2023 /PRNewswire-HISPANIC PR WIRE/ — Los investigadores han considerado que el método de cuidado “Comer, dormir, consolar” (Eat, Sleep, Console; ESC) es más efectivo que el uso de la Finnegan Neonatal Abstinence Scoring Tool (FNAST) para evaluar y…

NEW YORK, April 30, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of adidas AG (OTC: ADDYY, ADDDF) between May 3, 2018 and February 21, 2023, both dates inclusive (the…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.